Health

Eight Ways CBD Oil Can Help Migraine Headaches

CBD has played a role in minimizing stress for many individuals suffering from migraines. It can decrease the cortisol hormone and bring the endocannabinoid system to homeostasis, reducing the risk of an individual developing a migraine.

When you live with chronic migraines, sometimes it feels like you’ll be trapped inside these headaches forever. It can be debilitating, preventing you from going to work, caring for your family, or meeting social obligations.

If you’re looking for a new remedy, try CBD oil. This is the trendy and incredible substance that’s associated with treating a number of remedies. It’s supposed to handle anxiety, sleep problems, pain, and so much more. There’s even CBD oil for dogs.

When you’re ready to try CBD oil to relieve your chronic migraines, here are a few reasons it could be successful for your migraine disorder.

Relieves Pain

The first and most important point is that CBD relieves pain. The endocannabinoid system is responsible for regulating immune responses including pain. It’s believed that CBD works directly with the body’s endocannabinoid system, building up cannabinoid counts and binding with CB1 and CB2 receptors to inhibit the transmittal of pain signals to the brain. When the pain hits hard, CBD could be your biggest source of relief.

Targets Inflammation

Many studies indicate that inflammation plays a significant role in the contraction of migraines. It appears that migraines can sometimes occur because of fluid buildup around the brain and surrounding soft tissues. In other cases, inflammation can occur as a result of the migraine pain.

CBD has been linked in several studies to reducing inflammation and fluid buildup throughout the body. It’s commonly used to treat arthritis and sore muscles for athletes after a difficult workout.

Reduces Frequency of Migraines

The basis for this claim comes from a 2016 study that indicates that cannabis products like CBD could reduce the frequency of migraine headaches.The study found that patients who were under the influence of cannabis products had fewer migraines per month than those who did not use cannabis products.

It’s not clear why the migraines were fewer for cannabis users in this study. Further research will need to occur to make that clear, but it’s promising enough to encourage a try!

Prevents Opioid Dependence

For many suffering with severe chronic migraines, opioid painkillers are the only tools to improve the pain. Unfortunately, these painkillers come with many risks and side effects, not the least of which is dependence or substance abuse.

The jury is still out on whether or not CBD is as effective as opioids in killing pain, but it’s at least not habit-forming and has very few side effects for those who get the dosage right. Additionally, CBD is often used as an aid for overcoming addiction. It helps to reduce symptoms of withdrawal while individuals work to remove the dependence.

Treats Anxiety Associated with Migraines

Those who experience chronic pain often develop anxiety as a result. They fear the worst when the pain begins, and even before it begins, they worry that they’ll have a migraine that will impede their ability to function for the day.

CBD is one of the best treatments for anxiety. When CBD interacts with the body’s endocannabinoid system, it helps to regulate hormones that cause anxiety. As cortisol levels drop and serotonin increases with CBD, the user tends to feel calmer, which could also help to minimize triggers for migraines.

Calms the Stomach

When taken in the right dosage, CBD can cause nausea. However, it’s more often used to treat symptoms associated with a distressed stomach. As a common side effect of migraines, gastrointestinal issues could be calmed with CBD.

A part of this calming power comes from the ability to reduce inflammation. Any swelling in the bowels can be minimized with CBD, helping to relieve vomiting, diarrhea, gas, and other issues.

Improves Sleep

Sleep and migraines are part of a vicious cycle mercilessly playing off of each other. When you don’t get enough sleep, you’re more likely to get a migraine. Migraines can also keep you awake, preventing you from getting adequate sleep.

CBD is a known sleep aid that has great effects with minimal side effects. At the right dosage, it helps users feel drowsy when they’re ready to fall asleep, ignoring anxiety and pain that might otherwise keep them awake. It also improves the sleep cycle and helps individuals reset their circadian rhythms. Best of all, you’re unlikely to feel drowsy when you awake, giving you a fully restful night’s sleep.

Minimizes Stress

Stress is another catch 22 for migraines. It can be caused by migraines and cause them. Stress causes tension in the muscles and neck while building up cortisol in the brain. All of these can contribute to painful and often debilitating headaches for those with migraine disorders.

Once you’ve decided to give the best CBD oil for migraines a try, it’s important to get just the right dosage for your needs.

“There is no standard CBD treatment plan for migraines that I’m aware of, since people’s responses to any of the cannabinoids can vary greatly,” Kenneth Weinberg, MD and chief medical officer at Cannabis Doctors of New York told POPSUGAR. “Having said that, the usual dose of CBD oil in most situations is 25 milligrams. This should be taken when the first signs of migraine, or its aura, appear.”

Dr. Weinberg continues to explain that if you don’t feel relief within 15 to 20 minutes of taking CBD, you can take a second dose as needed. He recommends keeping track of how much CBD you take and how it affects you. Usually, if you notice many adverse side effects, the dose is too strong. If you notice no effects at all, it’s too gentle.

Health

Report Causes Pfizer Stock to Climb Approximately $1 Billion Acquired by Starboard

(VOR News) – According to a rumor that activist investor Pfizer Starboard Value has taken a holding in the struggling pharmaceutical business that is expected to be worth around one billion dollars, the stock of Pfizer (PFE) is on the increase in premarket trading on Monday.

This comes after the report was made public. The report was made available to the general public following this. Starboard Value was successful in moving forward with the acquisition of the position.

Starboard is said to have approached Ian Read, a former chief executive officer of Pfizer, and Frank D’Amelio, a former chief financial officer, in order to seek assistance with its goals of boosting the performance of the company, according to the Wall Street Journal. Read and D’Amelio are both former Pfizer executives.

The purpose of this is to facilitate the accomplishment of its objectives, which include enhancing the overall performance of the firm.

In their previous jobs, D’Amelio and Read were chief financial officers.

It is stated in the report that the hedge fund is of the opinion that Pfizer, which is currently being managed by Albert Bourla, who succeeded Read as Chief Executive Officer (CEO) in 2019, does not demonstrate the same level of mergers and acquisitions (M&A) discipline that Read did. Bourla took over for Read in 2019. Read was succeeded by Bourla in the year 2019.

Pfizer, a multinational pharmaceutical conglomerate, has made substantial investments in the acquisition of more companies that are involved in the research and development of cancer medicines.

These businesses have been acquired for billions of dollars. The biotechnology company Seagen, which was acquired by Pfizer in the previous year for a price of $43 billion, is included in this category. One of the businesses that can be classified as belonging to this category is Seagen.

In spite of the fact that the S&P 500 Index experienced a 21% increase in 2024.

No major trading occurred in Pfizer stock that year.

Due to the fact that the demand for Pfizer’s COVID-19 vaccines fell after the firm reached its pandemic peak in 2021, the share price of the corporation has decreased by over fifty percent since that time.

This drop has occurred ever since the company’s shares reached their maximum peak, which was during the time that this decline occurred. Not only have they not changed at all, but they have also remained essentially stable. This is in contrast to the S&P 500, which has gained 21% since the beginning of this year.

Recently, the corporation was forced to take a hit when it decided to recall all of the sickle cell illness medications that it had distributed all over the world.

Fears that the prescription could lead patients to experience severe agony and possibly even death were the impetus for the decision to recall the product. In spite of the fact that Pfizer’s stock is increasing by almost three percent as a result of the news that followed the company’s decision, this is the circumstance that has come about.

SOURCE: IPN

Health

New Study Reveals Drinking Soda Pop Increases the Risk of Stroke

If you drink too much soda, fruit juice and coffee, beware!

A recent report from global research indicates that excessive consumption of coffee or soda pop is associated with an increased risk of stroke, although the intake of black and green tea is correlated with a reduced risk. Excessive consumption of soda pop or coffee warrants caution!

Recent research indicates that it may substantially elevate the risk of stroke.

Consuming four cups of coffee daily elevates the risk of stroke, according to studies, although ingesting 3-4 cups of black or green tea daily typically offers protection against stroke. Additionally, consume more coffee; it may reduce your risk of mortality.

Recent findings from global research studies co-led by the University of Galway and McMaster University, alongside an international consortium of stroke researchers, indicate that soda, encompassing both sugar-sweetened and artificially sweetened variants such as diet or zero sugar, is associated with a 22 percent heightened risk of stroke. The risk escalated significantly with the consumption of two or more of these beverages daily.

Stroke Risk Fizzy Drinks and Soda Pop

The correlation between fizzy drinks consumption and stroke risk was most pronounced in Europe, the Middle East, Africa, and South America. Women exhibit the most elevated risk of stroke from bleeding (intracranial hemorrhage) associated with fruit juice beverages. Consuming over 7 cups of water daily diminishes the likelihood of stroke due to a clot.

Researchers observed that numerous items advertised as fruit juice are derived from concentrates and have added sugars and preservatives, potentially negating the advantages often associated with fresh fruit and instead elevating stroke risk.

Fruit juice beverages were associated with a 37 percent heightened risk of stroke resulting from bleeding (intracranial hemorrhage). Consuming two of these beverages daily increases the risk thrice.

Consuming over four cups of coffee daily elevates the risk of stroke by 37 percent, although lower consumption levels do not correlate with stroke risk. Conversely, tea consumption was associated with an 18-20 percent reduction in stroke risk. Additionally, consuming 3-4 cups daily of black tea, such as Breakfast and Earl Grey varieties, excluding green and herbal teas, was associated with a 29 percent reduced risk of stroke.

Consuming 3-4 cups of green tea daily was associated with a 27 percent reduction in stroke risk. Notably, the addition of milk may diminish or inhibit the advantageous effects of antioxidants present in tea. The lower risk of stroke associated with tea consumption was negated for individuals who added milk.

Disclaimer: This article is intended solely for informational reasons and should not be considered a replacement for professional medical counsel. Consistently consult your physician regarding any inquiries pertaining to a medical problem.

Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition

Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition

Health

Following a Diagnosis of Breast Cancer, What Else Should You Know?

(VOR News) – Even though breast cancer affects one in eight American women, receiving a diagnosis can make a woman feel isolated.

Experts in breast cancer from the American College of Physicians (ACS) advise patients on how to manage their disease so that they may better cope with this awful information.

First, the kind and stage of breast cancer dictates the course of your care.

In addition to immunotherapy and chemotherapy, there are various surgical options available for the treatment of breast cancer.

Women of African descent are disproportionately affected by triple-negative breast cancer, an extremely aggressive form of the disease that has never proven easy to treat.

According to the American Cancer Society, pembrolizumab (Keytruda), an immunotherapy, has been shown to be helpful when combined with chemotherapy and is currently the recommended course of treatment for certain combinations of triple-negative breast cancer.

In her presentation, Dr. Katharine Yao said, “It’s really important that the patient and physician discuss the patient’s preferences and values when deciding what type of treatment to pursue and that they have an honest, individualized discussion with their care team.”

She is currently responsible for developing breast cancer treatment recommendations for more than 575 hospitals and institutions nationwide in her role as chair of the American College of Surgeons’ National Accreditation Program for Breast Institutions (NAPBC).

Yao, vice chair of research at Endeavor Health NorthShore Hospitals in New York, pointed out that each decision made about a patient’s treatment plan should take her preferences and diagnosis into consideration.

She ought to think about whether she would prefer a mastectomy—a surgical procedure that involves removing the entire breast with or without reconstruction—or a lumpectomy, which involves a surgical procedure that spares part of the breast tissue.

She stated that “the breast cancer you have may be very different from the breast cancer you hear about in your neighbor, colleague, or friend” in a press release issued by the American Cancer Society (ACS).

“Consider that while discussing breast cancer with others.”

Throughout your journey, it is critical that you look after your emotional health because having breast cancer may have a detrimental impact on your mental health.

“Getting a cancer diagnosis does not mean that everything in your life stops to be normal.” Director of the Fellowship in the Diseases of the Breast program at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas and state head of the American Cancer Society Commission on Cancer for Arkansas, Dr. Daniela Ochoa She thinks adding the burden of a cancer diagnosis and treatment to all the other pressures in life may be taxing.

“Managing stress and emotional health is vital component of a treatment plan.”

Ochoa recommends clinically trained psychologists and social workers who have assisted people in coping with cancer to anyone receiving treatment. Learning coping techniques might also be facilitated by joining cancer support groups or cancer wellness initiatives.

Breast cancer specialists say your care team is crucial.

The American Cancer Society (ACS) defines comprehensive care as having support at every stage of the procedure from surgeons, oncologists, patient navigators, nurses, social workers, psychologists, and other specialists.

After receiving a breast cancer diagnosis, women should see a surgeon or medical oncologist to explore their options; nevertheless, treatment shouldn’t be discontinued after just one appointment or after surgery is over.

Additionally, you can ask trustworthy friends or family members to accompany you to appointments and aid you with research or notes. They could serve as a network of support for you.

Yao stated in his talk that “one of the most important things is that patients should search out a team they have confidence in, that they trust will have their back when they need it, and a team they feel they can get access to and that will help them when they are in need.”

SOURCE: MP